AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15722905 — intervention group
Group type: COMPARATOR
Intervention: (99m)Tc HMPAO labelled white cell imaging
Number of subjects: 22
Study 15722905 — intervention group
Group type: EXPERIMENTAL
Intervention: LeukoScan planar images at 2 h
Number of subjects: 22
Study 15722905 — intervention group
Group type: EXPERIMENTAL
Intervention: LeukoScan planar images at 4 h
Number of subjects: 22
Study 12849765 — intervention group
Group type: EXPERIMENTAL
Intervention: Right frontal lesions group (patients with right frontal lesions)
Number of subjects: 67
Study 12849765 — intervention group
Group type: EXPERIMENTAL
Intervention: Left frontal lesions group (patients with left frontal lesions)
Number of subjects: 67
Study 12849765 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 67
Study 12849765 — intervention group
Group type: EXPERIMENTAL
Intervention: Right frontal lesions group
Number of subjects: 67
Study 12849765 — intervention group
Group type: EXPERIMENTAL
Intervention: Left frontal lesions group and right frontal lesions group
Number of subjects: 67
Study 10374198 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 8
Study 10374198 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving thrombolytic agents)
Number of subjects: 8
Study 8911009 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet injector
Number of subjects: 147
Study 8911009 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (i.m.)
Number of subjects: 147
Study 8911009 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous (s.c.)
Number of subjects: 147
Study 1846723 — intervention group
Group type: EXPERIMENTAL
Intervention: Instant oats (2 servings per day, approximately two ounces dry weight)
Number of subjects: 0
Study 1846723 — intervention group
Group type: COMPARATOR
Intervention: Control group (no oats)
Number of subjects: 0
Study 6344914 — intervention group
Group type: EXPERIMENTAL
Intervention: Early elective splenectomy
Number of subjects: 169
Study 6344914 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic features
Number of subjects: 169
Study 31925799 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg daily
Number of subjects: 101
Study 31925799 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oral oestradiol-17β 2 mg plus norethisterone acetate 1 mg daily (E2/NETA)
Number of subjects: 101
Study 31925799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 31263933 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub mucosal partial inferior turbinectomy
Number of subjects: 110
Study 31263933 — intervention group
Group type: COMPARATOR
Intervention: Out fracture of inferior turbinate
Number of subjects: 110
Study 29453467 — intervention group
Group type: COMPARATOR
Intervention: Standard dose magnesium sulfate
Number of subjects: 60
Study 29453467 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose only magnesium sulfate
Number of subjects: 60
Study 26795675 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad with access to the personalized inpatient portal
Number of subjects: 426
Study 26795675 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad with general internet access
Number of subjects: 426
Study 26795675 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 426
Study 24647513 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal fixation with two screws (n = 78)
Number of subjects: 143
Study 24647513 — intervention group
Group type: COMPARATOR
Intervention: Cemented total hip replacement (n = 68)
Number of subjects: 143
Study 21600848 — intervention group
Group type: EXPERIMENTAL
Intervention: CD recording of consultation (n=10)
Number of subjects: 17
Study 21600848 — intervention group
Group type: COMPARATOR
Intervention: No CD (Control group, n=7)
Number of subjects: 17
Study 20726625 — intervention group
Group type: EXPERIMENTAL
Intervention: SABA (short-acting beta-agonists)
Number of subjects: 0
Study 20726625 — intervention group
Group type: EXPERIMENTAL
Intervention: Leukotriene receptor antagonists (LTRA)
Number of subjects: 0
Study 20726625 — intervention group
Group type: EXPERIMENTAL
Intervention: Mast cell stabilizers (MCS) (nedocromil sodium)
Number of subjects: 0
Study 20726625 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval warmup
Number of subjects: 0
Study 20726625 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 0
Study 20726625 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous low intensity warmup
Number of subjects: 0
Study 20726625 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous high intensity warmup
Number of subjects: 0
Study 20726625 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily LABA (salmeterol)
Number of subjects: 0
Study 20726625 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily SABA
Number of subjects: 0
Study 20726625 — intervention group
Group type: COMPARATOR
Intervention: Mast cell stabilizers (MCS) plus SABA
Number of subjects: 0
Study 18029469 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/d rosuvastatin
Number of subjects: 12
Study 18029469 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/d rosuvastatin
Number of subjects: 12
Study 18029469 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 15967175 — intervention group
Group type: EXPERIMENTAL
Intervention: Angry participants
Number of subjects: 84
Study 15967175 — intervention group
Group type: EXPERIMENTAL
Intervention: Angry and anxious participants
Number of subjects: 84
Study 11850709 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Cell (BC) collection
Number of subjects: 64
Study 11850709 — intervention group
Group type: COMPARATOR
Intervention: Bone Marrow (BM) collection
Number of subjects: 64
Study 10613433 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic fitness measured by VO2max
Number of subjects: 298
Study 10613433 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic fitness measured by T(VE)
Number of subjects: 298
Study 10613433 — intervention group
Group type: EXPERIMENTAL
Intervention: VO2max relative to body mass
Number of subjects: 298
Study 10613433 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum level of aerobic power compatible with independent life
Number of subjects: 298
Study 7907950 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxotere (docetaxel) intravenous infusion at doses of 70-115 mg/m2 every 3 weeks
Number of subjects: 0
Study 7907950 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxotere (docetaxel) intravenous infusion
Number of subjects: 0
Study 3002163 — intervention group
Group type: EXPERIMENTAL
Intervention: High fiber diet (27 g/1000 kcal)
Number of subjects: 0
Study 3002163 — intervention group
Group type: COMPARATOR
Intervention: Normal fiber diet (11 g/1000 kcal)
Number of subjects: 0
Study 30188014 — intervention group
Group type: EXPERIMENTAL
Intervention: RUSleeping® (portable monitoring device)
Number of subjects: 114
Study 30188014 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysomnography (PSG)
Number of subjects: 114
Study 30188014 — intervention group
Group type: EXPERIMENTAL
Intervention: Epworth Sleepiness Scale
Number of subjects: 114
Study 30188014 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple questionnaire
Number of subjects: 114
Study 30188014 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean apnea-hypopnoea index (AHI)
Number of subjects: 114
Study 30188014 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate logistic regression analysis
Number of subjects: 114
Study 26539650 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg
Number of subjects: 1146
Study 26539650 — intervention group
Group type: EXPERIMENTAL
Intervention: atorvastatin 10 mg
Number of subjects: 1146
Study 26539650 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 20 mg
Number of subjects: 1146
Study 26539650 — intervention group
Group type: EXPERIMENTAL
Intervention: pravastatin 40 mg
Number of subjects: 1146
Study 26539650 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg
Number of subjects: 1146
Study 26539650 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 40 mg
Number of subjects: 1146
Study 26539650 — intervention group
Group type: EXPERIMENTAL
Intervention: atorvastatin 40 mg
Number of subjects: 1146
Study 26539650 — intervention group
Group type: EXPERIMENTAL
Intervention: atorvastatin 80 mg
Number of subjects: 1146
Study 26539650 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin (all doses)
Number of subjects: 1146
Study 26539650 — intervention group
Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 1146
Study 26180214 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic warning labels (GWLs)
Number of subjects: 4436
Study 26180214 — intervention group
Group type: COMPARATOR
Intervention: Text-only warning labels (control)
Number of subjects: 4436
Study 23442391 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics capsules containing > 1x10(9) cfu each of Lactobacillus rhamnosus GG and Bifidobacterium lactis BB‐12 per capsule, administered from 16 weeks gestation until delivery.
Number of subjects: 540
Study 23442391 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules, administered from 16 weeks gestation until delivery.
Number of subjects: 540
Study 23442391 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 540
Study 23442391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540
Study 20852880 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise of elbow flexors (EF)
Number of subjects: 17
Study 20852880 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise of elbow extensors (EE)
Number of subjects: 17
Study 20852880 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise of knee flexors (KF)
Number of subjects: 17
Study 20852880 — intervention group
Group type: COMPARATOR
Intervention: Eccentric exercise of knee extensors (KE)
Number of subjects: 17
Study 19114190 — intervention group
Group type: EXPERIMENTAL
Intervention: Special acupuncture technique (preoperative implantation of small intradermal needles retained for 4 weeks)
Number of subjects: 162
Study 19114190 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture technique (preoperative placement of sham needles)
Number of subjects: 162
Study 17136231 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic administration of ibuprofen on the first day of life
Number of subjects: 0
Study 17136231 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic administration of ibuprofen to induce closure of a symptomatic PDA
Number of subjects: 0
Study 12600800 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 1350
Study 12600800 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) with strong, subnoxious electrical stimulation
Number of subjects: 1350
Study 12600800 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) without explicit confirmation of sufficient current intensity and adequate frequency
Number of subjects: 1350
Study 12600800 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1350
Study 11144434 — intervention group
Group type: EXPERIMENTAL
Intervention: BF-supplemented WHO ORS
Number of subjects: 150
Study 11144434 — intervention group
Group type: COMPARATOR
Intervention: WHO ORS
Number of subjects: 150
Study 9547777 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.2-mm incision
Number of subjects: 50
Study 9547777 — intervention group
Group type: COMPARATOR
Intervention: 3.5-mm incision
Number of subjects: 50
Study 9547777 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 7826833 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose metoclopramide (7 mg kg‐1 day‐1)
Number of subjects: 32
Study 7826833 — intervention group
Group type: COMPARATOR
Intervention: Alizapride (5 mg kg‐1 day‐1)
Number of subjects: 32
Study 3059898 — intervention group
Group type: EXPERIMENTAL
Intervention: poncho wrap, negative-pressure ventilator
Number of subjects: 20
Study 3059898 — intervention group
Group type: COMPARATOR
Intervention: standard care
Number of subjects: 20
Study 29937115 — intervention group
Group type: EXPERIMENTAL
Intervention: Keep It Up! intervention
Number of subjects: 901
Study 29937115 — intervention group
Group type: COMPARATOR
Intervention: Control condition (existing online HIV information)
Number of subjects: 901
Study 27860292 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring through frequent interviews
Number of subjects: 145
Study 27860292 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 145
Study 26197707 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg/day
Number of subjects: 32
Study 26197707 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 23568575 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (10 mg)
Number of subjects: 0
Study 23568575 — intervention group
Group type: COMPARATOR
Intervention: Scopolamine (0.6 mg)
Number of subjects: 0
Study 21926189 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored cognitive-behavioural therapy and exercise training (16 twice-weekly sessions)
Number of subjects: 0
Study 21926189 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group (WLC)
Number of subjects: 0
Study 19033840 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency incision
Number of subjects: 23
Study 19033840 — intervention group
Group type: COMPARATOR
Intervention: Scalpel incision
Number of subjects: 23
Study 17209739 — intervention group
Group type: EXPERIMENTAL
Intervention: Masking the upper half of the face
Number of subjects: 220
Study 17209739 — intervention group
Group type: EXPERIMENTAL
Intervention: Masking the lower half of the face
Number of subjects: 220
Study 17209739 — intervention group
Group type: EXPERIMENTAL
Intervention: Masking the eye region
Number of subjects: 220
Study 17209739 — intervention group
Group type: EXPERIMENTAL
Intervention: Masking the mouth region
Number of subjects: 220
Study 17209739 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of kinship information from two halves of the face
Number of subjects: 220
Study 12850126 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodropropizine 6% drops administered orally t.i.d. for 10 consecutive administrations
Number of subjects: 24
Study 11000359 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 17
Study 11000359 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 17
Study 8616085 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation from partially HLA-mismatched related donors
Number of subjects: 52
Study 8616085 — intervention group
Group type: COMPARATOR
Intervention: Bone marrow transplantation from HLA-identical siblings
Number of subjects: 52
Study 1555693 — intervention group
Group type: EXPERIMENTAL
Intervention: Short regimen of gonadotropin-releasing hormone agonist
Number of subjects: 87
Study 1555693 — intervention group
Group type: COMPARATOR
Intervention: Long regimen of gonadotropin-releasing hormone agonist
Number of subjects: 87
Study 2580288 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitreous carbon tip leads
Number of subjects: 150
Study 2580288 — intervention group
Group type: COMPARATOR
Intervention: Elgiloy tip leads
Number of subjects: 150
Study 31779992 — intervention group
Group type: EXPERIMENTAL
Intervention: Shotblocker
Number of subjects: 0
Study 31779992 — intervention group
Group type: COMPARATOR
Intervention: Control (no Shotblocker)
Number of subjects: 0
Study 29397091 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal steam bath
Number of subjects: 64
Study 29397091 — intervention group
Group type: COMPARATOR
Intervention: Steam bath without herbs
Number of subjects: 64
Study 27449274 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence intervention
Number of subjects: 1462
Study 25194505 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile 3D viewing
Number of subjects: 26
Study 22370698 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg oral melatonin daily for 4 months
Number of subjects: 95
Study 22370698 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 20822027 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingfeihuayu soup, two times a day
Number of subjects: 82
Study 20822027 — intervention group
Group type: COMPARATOR
Intervention: Rocephin 2 g once daily for 7 days
Number of subjects: 82
Study 17400756 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutting PTA
Number of subjects: 114
Study 17400756 — intervention group
Group type: COMPARATOR
Intervention: Conventional PTA
Number of subjects: 114
Study 15625610 — intervention group
Group type: EXPERIMENTAL
Intervention: Stone Cone
Number of subjects: 56
Study 15625610 — intervention group
Group type: COMPARATOR
Intervention: Standard flat wire basket
Number of subjects: 56
Study 12394728 — intervention group
Group type: EXPERIMENTAL
Intervention: Blinded review
Number of subjects: 234
Study 12394728 — intervention group
Group type: COMPARATOR
Intervention: Unblinded review
Number of subjects: 234
Study 10430393 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic upper abdominal chemotherapy (Mitomycin‐C, 5‐Fluorouracil, Leucovorin, Farmorubicin) plus systemic chemotherapy
Number of subjects: 58
Study 10430393 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic upper abdominal chemotherapy (Mitomycin‐C, 5‐Fluorouracil, Leucovorin, Farmorubicin) without systemic chemotherapy
Number of subjects: 58
Study 10430393 — intervention group
Group type: COMPARATOR
Intervention: No neo or adjuvant treatment
Number of subjects: 58
Study 7571220 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin 4 mg/day for 3 months (after a 3-week titration period)
Number of subjects: 63
Study 7571220 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin 8 mg/day for 3 months (after a 3-week titration period)
Number of subjects: 63
Study 7571220 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin administered in the morning or evening
Number of subjects: 63
Study 7571220 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events (dizziness in 5 patients, fatigue in 4)
Number of subjects: 63
Study 2076734 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-dergocrine mesylate (Cod) 4 mg followed by Nifedipine (Nif) 20 mg
Number of subjects: 18
Study 2076734 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (Nif) 20 mg with placebo as premedication
Number of subjects: 18
Study 2076734 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (Nif) 20 mg with Cod as premedication
Number of subjects: 18
Study 2076734 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (Nif) 20 mg
Number of subjects: 18
Study 495541 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamin intake of 0.30 mg per 1000 kcal (derived from carbohydrate sources)
Number of subjects: 0
Study 495541 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamin intake of 0.40 mg per 1000 kcal (recommended by FAO/WHO)
Number of subjects: 0
Study 495541 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamin intake of 0.5 mg per 1000 kcal (recommended by Food and Nutrition Board of NAS‐NRC)
Number of subjects: 0
Study 495541 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythrocyte transketolase activity and urinary excretion of thiamin
Number of subjects: 0
Study 495541 — intervention group
Group type: EXPERIMENTAL
Intervention: Microbiological assay (Lactobacillus viridescens) for measuring thiamin levels in urine
Number of subjects: 0
Study 31349906 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided PIV placement with guidewire
Number of subjects: 69
Study 31349906 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided PIV placement without guidewire
Number of subjects: 69
Study 31480045 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantoprazole (intravenously once daily during ICU stay, until ICU discharge, death, or a maximum of 90 days)
Number of subjects: 3291
Study 31480045 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intravenously once daily during ICU stay, until ICU discharge, death, or a maximum of 90 days)
Number of subjects: 3291
Study 28538380 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet (30 mg)
Number of subjects: 21
Study 28538380 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 25844682 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser irradiation
Number of subjects: 30
Study 25844682 — intervention group
Group type: COMPARATOR
Intervention: Control group (same laser without laser emission)
Number of subjects: 30
Study 23457307 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) for 6 months
Number of subjects: 56
Study 23457307 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study 21879181 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal ozone therapy
Number of subjects: 64
Study 21879181 — intervention group
Group type: COMPARATOR
Intervention: Rectal medicinal oxygen
Number of subjects: 64
Study 21879181 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 64
Study 19453516 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute psychological stress (IQ test)
Number of subjects: 25
Study 19453516 — intervention group
Group type: COMPARATOR
Intervention: Control task
Number of subjects: 25
Study 16732007 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 476
Study 16732007 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 476
Study 15301647 — intervention group
Group type: EXPERIMENTAL
Intervention: Panic Control Therapy (PCT)
Number of subjects: 80
Study 15301647 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 80
Study 11503783 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin + Paclitaxel
Number of subjects: 0
Study 11503783 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (monotherapy)
Number of subjects: 0
Study 11503783 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin + Etoposide
Number of subjects: 0
Study 11503783 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin + Teniposide
Number of subjects: 0
Study 9071861 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron deficiency intervention
Number of subjects: 320